An orally available tubulin inhibitor, VERU-111, to overcome paclitaxel resistance and to suppress breast cancer tumor growth and metastasis.
2018 ◽
Vol 36
(15_suppl)
◽
pp. e13110-e13110
Keyword(s):
2018 ◽
2019 ◽
Vol 19
(2)
◽
pp. 348-363
◽
Keyword(s):
2019 ◽
Vol 145
(10)
◽
pp. 2767-2780
◽
Keyword(s):
2016 ◽
Keyword(s):
2016 ◽
Vol 28
(2)
◽
pp. 461-470
◽
Keyword(s):
Keyword(s):